| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 09/02/2004 | CA2478473A1 Aldosterone blocker therapy to prevent or treat inflammation-related disorders |
| 09/01/2004 | EP1452524A1 "2-oxo-1-pyrrolidine derivative and its pharmaceutical uses" |
| 09/01/2004 | EP1452521A1 Cyclic compound and ppar agonist |
| 09/01/2004 | EP1452182A1 Angiogenesis drugs |
| 09/01/2004 | EP1452181A1 Regulation of immune responses by manipulation of intermediary metabolite levels |
| 09/01/2004 | EP1452176A1 Insulin resistance improving agents |
| 09/01/2004 | EP1451578A2 Composition comprising and method of using angiopoietin-like protein 3 angptl3 |
| 09/01/2004 | EP1451577A2 Soluble cd40l(cd154) as a prognostic marker of atherosclerotic diseases |
| 09/01/2004 | EP1451369A2 Methods and compositions to treat cardiovascular disease usin g 1419, 58765 and 2201 |
| 09/01/2004 | EP1451303A1 Detection of haematopoietic stem cells and progeny and uses thereof |
| 09/01/2004 | EP1451227A2 Method for controlling angiogenesis in animals |
| 09/01/2004 | EP1451226A1 Antigen presenting cell targeting conjugate, an antigen presenting cell contacted with such conjugate, their use for vaccination or as medicament, and methods for their production or generation |
| 09/01/2004 | EP1451222A2 Novel proteins with il-6 inhibiting activity |
| 09/01/2004 | EP1451212A2 Structural and cytoskeleton-associated proteins |
| 09/01/2004 | EP1451210A2 Hepta-, octa- and nonapeptides having antiangiogenic activity |
| 09/01/2004 | EP1451209A2 Tetra-,penta-,hexa- and heptapeptides having antiangiogenic activity |
| 09/01/2004 | EP1451208A2 Concentrating aqueous fractions of lisinopril by reverse osmosis |
| 09/01/2004 | EP1451202A1 Aryl fused azapolycyclic compounds |
| 09/01/2004 | EP1451196A1 The use of anti-histaminics for acute reduction of elevated intracranial pressure |
| 09/01/2004 | EP1451190A1 Triazolo(4,3-a)pyrido(2,3-d)pyrimidin-5-one derivatives, compositions containing same, preparation method and use thereof |
| 09/01/2004 | EP1451185A1 Indole-2-carboxamides as factor xa inhibitors |
| 09/01/2004 | EP1451177A1 Substituted 2-pyrrolidine-2-yl-1h-indole derivatives for the treatment of migraine |
| 09/01/2004 | EP1451172A1 Therapeutic isoquinoline compounds |
| 09/01/2004 | EP1451169A1 Novel compounds for the treatment of cardiac arrhythmia, synthesis, and methods of use |
| 09/01/2004 | EP1451166A1 Citric acid salt of a therapeutic compound and pharmaceutical compositions thereof |
| 09/01/2004 | EP1451165A1 Substituted benzoxazoles and analogues as estrogenic agents |
| 09/01/2004 | EP1451158A1 Therapeutic quinoline compounds with 5-ht-antagonistic properties |
| 09/01/2004 | EP1451157A1 Therapeutic quinolone compounds with 5-ht-antagonistic properties |
| 09/01/2004 | EP1451156A1 4-aminoquinoline compounds |
| 09/01/2004 | EP1451153A1 Nk1 antagonists |
| 09/01/2004 | EP1451151A1 Hydroperylene derivatives |
| 09/01/2004 | EP1450901A2 (1-phenyl-2-heteroaryl)ethyl-guanidine compounds as inhibitors of mitochondrial f1f0 atp hydrolase |
| 09/01/2004 | EP1450862A1 Replication competent dual-ad vectors for vaccine and immunotherapy applications |
| 09/01/2004 | EP1450851A1 Treatment of congestive heart failure |
| 09/01/2004 | EP1450842A2 Process of preparation of formulations of the peptide angiotensin-(1-7) and its analogues, agonistic and antagonists using cyclodextrins, lipossomes and biodegradable polymers and/or mixtures and products thereof |
| 09/01/2004 | EP1450837A2 Interleukin-1 receptors in the treatment of diseases |
| 09/01/2004 | EP1450834A1 Allium sativum bulb absolutes and therapeutic or cosmetic uses |
| 09/01/2004 | EP1450820A2 Method for treating or preventing inflammatory diseases |
| 09/01/2004 | EP1450816A2 Method of treating disorder related to high cholesterol concentration |
| 09/01/2004 | EP1450811A2 2-aryl pyrrolopyrimidines for a1 and a3 receptors |
| 09/01/2004 | EP1450801A2 2-aminoquinoline compounds |
| 09/01/2004 | EP1450797A1 Benzothiazole derivatives |
| 09/01/2004 | EP1450796A1 Benzothiazole derivatives |
| 09/01/2004 | EP1450793A2 Hypertonia treatment during the acute phase of a cerebrovascular accident |
| 09/01/2004 | EP1450792A1 Benzazole derivatives for the treatment of scleroderma |
| 09/01/2004 | EP1450791A1 Hydrazonopyrazole derivatives and their use as therapeutics |
| 09/01/2004 | EP1450786A1 Isoflavone concentrate and method for production thereof |
| 09/01/2004 | EP1450780A1 Use of 4-oxobutanoic acid derivatives in the treatment of inflammation |
| 09/01/2004 | EP1450779A1 Method for treating autoimmune diseases |
| 09/01/2004 | EP1450772A1 Micronized film-forming powder comprising an active substance |
| 09/01/2004 | EP1450769A1 Intraorally disintegrating valdecoxib compositions prepared by spray drying process |
| 09/01/2004 | EP1450750A2 Use of 2-amino-4-pyridylmethyl-thiazoline derivatives as inhibitors of inducible no-synthase |
| 09/01/2004 | EP1450666A2 Methods and compositions to treat cardiovascular disease using 139,258,1261,1486,2398,2414,7660,8587,10183,10550,12680,17921,32248,60489 or 93804 |
| 09/01/2004 | EP1450629A1 Solid and stable creatine/citric acid composition(s) and compositions containing carbohydrate(s) or hydrates thereof, method for the production and use thereof |
| 09/01/2004 | EP1261349A4 Compounds with chelation affinity and selectivity for first transition series elements and their use |
| 09/01/2004 | EP1218012B1 Use of alprostadil (prostaglandin e1) for producing a medicament for angioneogenesis |
| 09/01/2004 | EP1165528B1 Novel morpholine derivatives, method for the production thereof and pharmaceutical preparations containing said derivatives |
| 09/01/2004 | EP1165135B1 Methods of screening for compounds modulating fxr receptors |
| 09/01/2004 | EP1127058B1 Pyrazolopyridine derivatives as selective cox-2 inhibitors |
| 09/01/2004 | EP0984955B1 Substituted 2-(2,6-dioxopiperidin-3-yl)-phthalimides and 1-oxoisoindolines and method of reducing tnf alpha levels |
| 09/01/2004 | EP0944621B1 2-imidazolinylaminoindole compounds useful as alpha-2 adrenoceptor agonists |
| 09/01/2004 | EP0923530B1 Inhibition of matrix metalloproteases by substituted biaryl oxobutyric acids |
| 09/01/2004 | EP0880502B1 Aminoheterocyclic derivatives as antithrombotic or anticoagulant agents |
| 09/01/2004 | CN1525978A C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases |
| 09/01/2004 | CN1525974A Derivatives of triazolyl-imidazopyridine and of the triazolylpurines useful as ligands of the adenosine A2a receptor and their use as medicaments |
| 09/01/2004 | CN1525972A Hetero-bicyclic crf antagonists |
| 09/01/2004 | CN1525966A New compounds, which are potent inhibitors of Na<+>/Ca<2+> exchange mechanism and are useful in the treatment of arrhythmias |
| 09/01/2004 | CN1525956A Alpha -amino-n-hydroxy-acetamide derivatives |
| 09/01/2004 | CN1525955A Carboxamide-substituted phenylurea derivatives, process for their preparation and their use as medicaments |
| 09/01/2004 | CN1525862A Novel receptors for dollar i(helicobacter pylori) and use thereof |
| 09/01/2004 | CN1525858A A pharmaceutical composition comprising a nicotinic receptor partial antagonist and an antiemetic agent for modulating cholinergic function |
| 09/01/2004 | CN1525856A Stable high-concentration injection containing pyrazolone derivative |
| 09/01/2004 | CN1525855A Oral controlled release pharmaceutical composition for one-a-day therapy for the treatment and prophylaxis of cardiac and circulatory diseases |
| 09/01/2004 | CN1524857A Tartrate salt of a substituted dipeptide as growth hormone secretagogue |
| 09/01/2004 | CN1524854A Thiazolidine diketone derivatives, preparing process and application of pharmaceutical preparations of the same |
| 09/01/2004 | CN1524567A Xuefu Zhuyu soft capsule and its preparation method |
| 09/01/2004 | CN1524557A Ixeris sonchifolia pharmaceutical formulation and its preparation method |
| 09/01/2004 | CN1524537A Pharmaceutical composition for treaitng coronary heart disease |
| 09/01/2004 | CN1524533A Pharmaceutical preparation ingested via nose for treating ischemia cerebrovascular disease |
| 09/01/2004 | CN1524528A Medicament composition for treating coronary heart disease |
| 09/01/2004 | CN1524526A Double layer slow release preparation for nitrendipine |
| 09/01/2004 | CN1524525A Controlled release preparation for nitrendipine |
| 09/01/2004 | CN1524524A Controlled release preparation for nitrendipine of constant speed release |
| 09/01/2004 | CN1524523A Compound pressure-reduction preparation containing indapamide, angiotensin converzyme inhibitor and spironolactone |
| 09/01/2004 | CN1524522A Compound pressure-reduction preparation containing indapamide and angiotensin converzyme inhibitor |
| 09/01/2004 | CN1524521A Troxerutin for injection and method for preparing the same |
| 09/01/2004 | CN1164761C Process for producing product contg. antihypertensive tripeptides |
| 09/01/2004 | CN1164760C Tenascin-C nucleic acid ligands |
| 09/01/2004 | CN1164744C Preparing process of modification enzyme for earthworm fibrinolysin |
| 09/01/2004 | CN1164608C Astragalus saponin A with the function of resisting myocardial fibrillation |
| 09/01/2004 | CN1164579C Thiazole and oxazole derivatives and their pharmaceutical use |
| 09/01/2004 | CN1164574C Phenoxypropylamine compounds |
| 09/01/2004 | CN1164334C Sustained release formulation of peptide |
| 09/01/2004 | CN1164303C Chinese medicine for treating bradyrhythmia caused by hypotension |
| 09/01/2004 | CN1164293C Chinese-medicinal capsule for treating cardiovascular and cerebrovascular diseases |
| 09/01/2004 | CN1164289C Compound gingko leaf preparation and its making process |
| 09/01/2004 | CN1164280C Tibet medicine for treating angiocardiopathy and cerebrovascular disease |
| 09/01/2004 | CN1164272C Comoposition containing ligustrazine, penetrating skin paste agent of igustrazine and its preparation method |
| 09/01/2004 | CN1164271C Stable xylometazoline and oxymetazoline solution |
| 09/01/2004 | CN1164268C Process for preparing simvastation drip pill |